Article Information
PubMed
Published By
History
- Received August 6, 2005
- Revision received February 2, 2006
- Accepted February 2, 2006
- First published March 22, 2006.
- Version of record published March 22, 2006.
Copyright & Usage
Copyright © 2006 Society for Neuroscience 0270-6474/06/263335-10$15.00/0
Author Information
- Xiaobo Cen1,2,*,
- Atsumi Nitta1,*,
- Shin Ohya1,
- Yinglan Zhao1,
- Naoya Ozawa1,
- Akihiro Mouri1,
- Daisuke Ibi1,7,
- Li Wang2,
- Makiko Suzuki3,
- Kuniaki Saito3,
- Yasutomo Ito4,
- Tetsuya Kawagoe5,
- Yukihiro Noda1,6,
- Yoshihisa Ito1,7,
- Shoei Furukawa8, and
- Toshitaka Nabeshima1
- 1Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan, 2National Chengdu Center for Safety Evaluation of Traditional Chinese Medicine, West China Hospital, Sichuan University, Chengdu 610041, China, 3Department of Laboratory Medicine, Gifu University School of Medicine, Gifu 500-8705, Japan, 4Equipment Center for Research and Education, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan, 5Department of Research and Development, Initium, Tokyo, 107-0062, Japan, 6Division of Clinical Science in Clinical Pharmacy Practice, Management and Research, Faculty of Pharmacy, Meijo University, Nagoya 468-8503, Japan, 7Department of Pharmacology, College of Pharmacy, Nihon University, Funabashi-shi, Chiba 274-8555, Japan, and 8Laboratory of Molecular Biology, Gifu Pharmaceutical University, Gifu 502-8585, Japan
Author contributions
Disclosures
- Received August 6, 2005.
- Revision received February 2, 2006.
- Accepted February 2, 2006.
-
This work was supported in part by a grant-in-aid for Science Research and Special Coordination Funds for Promoting Science and Technology, Target-Oriented Brain Science Research Program KAKENHI, and the 21st Century Center of Excellence Program “Integrated Molecular Medicine for Neuronal and Neoplastic Disorders” from the Ministry of Education, Culture, Sports, Science and Technology of Japan; by a grant-in-aid for Health Science Research on Regulatory Science of Pharmaceuticals and Medical Devices, and Dementia and Fracture from the Ministry of Health, Labor and Welfare of Japan; and by a Smoking Research Foundation grant for Biomedical Research.
-
↵*A.N. and X.C. contributed equally to this work.
- Correspondence should be addressed to Toshitaka Nabeshima, Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Tsuruma-Cho, Showa-ku, Nagoya 466-8560, Japan. Email: tnabeshi{at}med.nagoya-u.ac.jp
Online Impact